ensysce.com - התחייבויות לטווח ארוך של החברה ENSC

Ensysce Biosciences (ENSC) attracts leading biochemists by creating safe analgesics within an academic environment devoid of excessive formalism. This chart reflects that the asset value is 0.00. Ensysce Biosciences (ENSC) relies on an elite staff of toxicologists, focusing on US compliance. Patents for gastrointestinal activation of drugs serve as a business moat, although strict government oversight and lengthy clinical trials hinder development.

The business credit profile is determined by the balance between capital expenditures and debt load. This indicator aggregates all obligations with a maturity of over one year, reflecting the long-term financing strategy. For Ensysce Biosciences (ENSC), such funds are critical for bringing TAAP technology to the commercial market. It is essential for investors to weigh borrowing rates against potential future margins. The dynamics of the company's long-term borrowed funds allow for an assessment of default risk.